secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001609550-26-000021
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical Q1 revenue up 1.6% to $204.6M; guides FY2026 revenue down 4-10%
-------------------------------------------------------------------------------

- GAAP diluted EPS $(0.39); adjusted diluted EPS $0.10; operating cash flow $12.8M.
- Coding/reimbursement uncertainty for Inspire V and WISeR program disrupted Q1.
- FY2026 revenue guidance revised to $825M-$875M (decline 4-10% vs 2025).
- Adjusted operating margin guidance of 2%-4%; adjusted diluted EPS $0.75-$1.25.
- Expects coding challenges to persist through 2026, with growth returning in 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955026000021/0001609550-26-000021-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955026000021/insp-20260504.htm
  HTML page:      https://secwatch.observer/filing/0001609550-26-000021

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer